We will always make our best efforts to develop innovative platform technologies and to be a global leader in the field of molecular diagnostics.

PANAGENE have been supplying Peptide Nucleic Acid (PNA) worldwide and exclusively since 2006 based on our unique invention of efficient synthesis of PNA with high purity, and nowadays we are possessing the best knowledge on PNA and the largest number of patents on the PNA and its applications in the world.

PNA, an artificial genetic material (a DNA mimic) invented at early 1990s, has been drawn much attention of researchers as a promising material candidate for especially diagnostic and therapeutic use, due to its advanced physicochemical properties such as strong binding affinity with complementary nucleic acids and superior biological/chemical stability.

We have been developing and launching accurate and convenient in vitro diagnostic products consistently. We exercise strict quality management policy and make efforts to meet global standards and appropriate regulations for our IVD products. We believe that results of our efforts to produce IVD products will greatly contribute for helping human healthcare in the future.

PANAGENE is pursuing open innovation and seeking opportunity for collaboration with various organizations including pharmaceutical and diagnostic companies. We always welcome contacts of organizations who are interest in our technologies and/or products.

We will do our best for customer satisfaction and for realizing our vision, “Platform Technology Provider”, we promise.

Please keep an eye on PANAGENE becoming a world leader in molecular diagnostics.